These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38212795)
1. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1. Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795 [TBL] [Abstract][Full Text] [Related]
2. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment. Zhang J; Ouyang F; Gao A; Zeng T; Li M; Li H; Zhou W; Gao Q; Tang X; Zhang Q; Ran X; Tian G; Quan X; Tang Z; Zou J; Zeng Y; Long Y; Li Y Mol Cancer; 2024 May; 23(1):94. PubMed ID: 38720298 [TBL] [Abstract][Full Text] [Related]
3. ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer. Liu Y; Yang R; Zhang Y; Zhu Y; Bao W J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864 [TBL] [Abstract][Full Text] [Related]
4. Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance. Li YK; Zeng T; Guan Y; Liu J; Liao NC; Wang MJ; Chen KX; Luo XY; Chen CY; Quan FF; Wang J; Zhang QF; Zou J Int J Biol Sci; 2023; 19(1):258-280. PubMed ID: 36594088 [No Abstract] [Full Text] [Related]
5. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib. Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601 [TBL] [Abstract][Full Text] [Related]
6. ANGPTL4 plays a paradoxical role in gastric cancer through the LGALS7 and Hedgehog pathways. Xie J; Li Y; Zeng T; Fan T; Shan H; Shi G; Zhou W; Zou J; Lei X Sci Rep; 2024 Oct; 14(1):23173. PubMed ID: 39369030 [TBL] [Abstract][Full Text] [Related]
7. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer. Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989 [TBL] [Abstract][Full Text] [Related]
8. ANGPTL4 regulates ovarian cancer progression by activating the ERK1/2 pathway. Xu J; Wu F; Zhu Y; Wu T; Cao T; Gao W; Liu M; Qian W; Feng G; Xi X; Hou S Cancer Cell Int; 2024 Feb; 24(1):54. PubMed ID: 38311733 [TBL] [Abstract][Full Text] [Related]
9. Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation. Wu Y; Gao J; Liu X Cancer Cell Int; 2021 Mar; 21(1):171. PubMed ID: 33726754 [TBL] [Abstract][Full Text] [Related]
10. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells. Feng W; Ting Y; Tang X; Liu D; Zhou WC; Li Y; Shen Z Heliyon; 2024 Sep; 10(17):e36897. PubMed ID: 39281564 [TBL] [Abstract][Full Text] [Related]
11. m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R/JAK1/STAT3 signaling by sponging miR-647. Wang R; Ye H; Yang B; Ao M; Yu X; Wu Y; Xi M; Hou M Int Immunopharmacol; 2023 Nov; 124(Pt A):110879. PubMed ID: 37713785 [TBL] [Abstract][Full Text] [Related]
12. Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8 Fan Z; Ye M; Liu D; Zhou W; Zeng T; He S; Li Y Int Immunopharmacol; 2024 Aug; 137():112461. PubMed ID: 38897128 [TBL] [Abstract][Full Text] [Related]
13. STAT2-induced linc02231 promotes tumorigenesis and angiogenesis through modulation of hnRNPA1/ANGPTL4 in colorectal cancer. Xu S; Fang Y; Chang L; Bian Y; Wang Y; Ding J; Wang Y; Zhang Y; Pu J; Wang K J Gene Med; 2023 Aug; 25(8):e3506. PubMed ID: 36994700 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway. Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling. Xie S; Li X; Yan J; Yu H; Chen S; Chen K Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977 [TBL] [Abstract][Full Text] [Related]
16. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways. Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479 [TBL] [Abstract][Full Text] [Related]
17. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway. Deng H; Gong X; Ji G; Li C; Cheng S Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene. Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899 [TBL] [Abstract][Full Text] [Related]
19. Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line. Benabbou N; Mirshahi P; Cadillon M; Soria J; Therwath A; Mirshahi M Int J Oncol; 2013 Sep; 43(3):685-94. PubMed ID: 23857432 [TBL] [Abstract][Full Text] [Related]
20. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling. Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]